Correlation Between DiaMedica Therapeutics and Lipocine

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Lipocine, you can compare the effects of market volatilities on DiaMedica Therapeutics and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Lipocine.

Diversification Opportunities for DiaMedica Therapeutics and Lipocine

0.24

Correlation Coefficient

DiaMedica Therapeutics  Lipocine

Modest diversification

The 3 months correlation between DiaMedica and Lipocine is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Lipocine go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Lipocine

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.72 times more return on investment than Lipocine. However, DiaMedica Therapeutics is 1.4 times less risky than Lipocine. It trades about 0.19 of its potential returns per unit of risk. Lipocine is currently generating about 0.1 per unit of risk. If you would invest  389.00  in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of  177.00  from holding DiaMedica Therapeutics or generate 45.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Lipocine

DiaMedica Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Lipocine

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with DiaMedica Therapeutics and Lipocine

The main advantage of trading using opposite DiaMedica Therapeutics and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.

The idea behind DiaMedica Therapeutics and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.